LATEST UPDATES » Vol 22, No 03, March 2018 – Women in Science - Making a difference       » Brain aging in ASEAN       » Chinese scientists find antidote to centipede venom       » Measuring the risks and rewards of drug development       » Ketone drink could help diabetics by lowering blood sugar       » What value-based healthcare means for Asia       » Improve healthcare access to tackle Asia's healthcare challenge      
New insight on therapeutic treatment for mental disorders
A novel regulation of DNA repair mechanism in neurons

Mental disorders affect millions of people around the world and also account for an increasingly significant proportion of medical expenses. A research team led by Dr. Yijuang Chern, a distinguished research fellow in the Institute of Biomedical Sciences at Academia Sinica, recently found a new mechanism underlying DNA repair in neurons. Their findings contribute to the current understanding of diseases with defects in DNA repair (such as mental diseases and neurodegenerative diseases). This study was published on 3 January 2018 in Molecular Psychiatry.

Generally speaking, the human body automatically metabolizes extraneous free radicals and repairs DNA sequences that are damaged by free radicals to ensure that cells function properly. Recent studies have discovered that neurons in patients suffering from mental illnesses show excessive presence of free radicals and the inability to fully repair damaged DNA.

When damaged DNA sequences cannot be properly repaired, these abnormal sequences will be replicated, resulting in abnormal neurotransmission, compromising neuronal survival, and aggravating the development of psychotic disorders. Therefore, how to restore and fix defective DNA repair mechanisms in neurons is a critical area of focus in research on mental disorders.

In their recent study, Dr. Chern and her team discovered a brand new complex that is related to the DNA repair mechanism in neurons—TDG complex. The TDG complex consists of TRAX (translin-associated protein X), DISC1 (disrupted-in-schizophrenia 1), and GSK3β (glycogen synthase kinase 3 beta).

TRAX is an interacting protein of the C-terminus of the A2A adenosine receptor (A2AR), which forms a complex with GSK3β and a risk gene for schizophrenia (DISC1). TRAX and DISC1 are proteins associated with mental disorders and that GSK3β kinase is associated with the ability to regulate DNA repair mechanisms. Dr. Chern’s team discovered that activation of A2AR leads to dissociation of the TRAX/DISC1/GSK3β complex (TDG complex).

This is of great interest because TRAX plays a critical role in detecting DNA damage by directly interacting with ATM to trigger the DNA repair machinery. Dissociation of the TDG complex facilitates the release of TRAX from the TDG complex and allows TRAX to enter the nucleus to facilitate DNA repair and subsequently enhance neuronal survival. Collectively, the TDG complex might serve as a potential therapeutic target for the development of novel treatments for diseases resulting from defects in DNA repair.

Although tremendous efforts have been devoted to the development of therapeutic treatments for mental disorders over the past decades, many important aspects regarding these disorders remained elusive. Findings regarding the TDG complex from this study offers new insight for illnesses resulting from deficiencies in DNA repair mechanisms and is expected to aid the development of new treatments for mental illnesses and neurodegenerative diseases in the future.

Click here for the complete issue.

news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
Asia Pacific Biotech News

Lady Ganga: Nilza'S Story
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
Obesity / Outlook for 2018
Searching for the fountain of youth
Women in Science - Making a difference
Digestive health / Intellectual property
Asthma / Dental health
Oncology / Biotech landscape in APAC
Water management / Vaccination
Regenerative medicine / Biotech start ups
Digital healthcare / 3D printing
Bones / Breast cancer
Liver health / Top science research nations & institutions
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy